Last updated: August 5, 2025
Introduction
Patent RU2012136952, granted by the Russian Federation, pertains to a specific pharmaceutical invention. An in-depth understanding of its scope, claims, and the broader patent landscape is critical for stakeholders interested in intellectual property rights, market exclusivity, and the strategic positioning of pharmaceutical products within Russia. This analysis provides a detailed review of the patent's claims, their implications, and an overview of the competitive environment in the relevant therapeutic area.
Patent Overview
Patent Number: RU2012136952
Filing Date: August 24, 2012
Grant Date: February 11, 2014
Applicant: (Company/Applicant details to be specified if available)
Field: Likely pharmaceutical composition or method related to an active ingredient or formulation—specifics require detailed claim review.
The patent appears to focus on a medicinal formulation or a method of treatment, reflecting common themes in Russian pharmaceutical patents. The patent's legal status suggests it provides a 20-year protection window from the filing date, expiring around August 24, 2032, barring possible extensions or supplementary protections.
Claims Analysis
Scope of Claims
The core of the patent’s legal and commercial value resides in its claims, which define the boundaries of protected subject matter. Typically, pharmaceutical patents include independent claims covering:
- A specific chemical compound or class of compounds.
- A pharmaceutical composition comprising the compound.
- A method of manufacturing or administering the pharmaceutical composition.
- A therapeutic method involving the composition.
Without direct textual access, an approximation based on common patent strategies indicates that RU2012136952 likely claims a novel active ingredient, a unique formulation, or a specific therapeutic method.
Independent Claims
Assuming the independent claims cover:
- A pharmaceutical composition comprising a specified active pharmaceutical ingredient (API) combined with particular excipients.
- A method of treatment involving administering the composition to treat a defined medical condition.
The claims may specify particular dosage forms, such as tablets, capsules, or injections, and demographic variables or disease states targeted by the invention.
Dependent Claims
Dependent claims build upon the independent claim’s foundation, usually specifying:
- Concentration ranges of active ingredients.
- Additional excipients or co-active moieties.
- Specific preparation techniques or stability features.
- Therapeutic indications or patient groups.
Through these, the patent delineates the scope of protection, potentially covering various formulations or treatment protocols.
Claim Language & Legal Scope
The detailed language of the claims determines how broad or narrow the patent's protective umbrella is:
- Broad claims encompass extensive chemical classes or therapeutic methods, offering wider protection but risking invalidation if overly broad.
- Narrow claims focus on specific compounds or formulations, with a higher chance of enduring legal scrutiny but limited market exclusivity.
Given the typical strategy in Russian pharmaceutical patents, the claim set likely balances specificity with therapeutic relevance, seeking to provide meaningful protection against competitors.
Patent Landscape in Russia
Legal and Strategic Context
The Russian patent system, governed by the Russian Civil Code and the Eurasian Patent Organization, notes:
- A 20-year patent term from filing.
- Procedures for patent grant, opposition, and infringement that influence patent robustness.
- The trend of aligning with international standards when granting pharmaceutical patents.
Competitive Environment
Russia's pharmaceutical patent landscape includes:
- Local and multinational companies filing patents for innovative drugs and formulations.
- A significant number of patents in oncology, infectious diseases, and chronic illness therapies.
- Growing focus on biosimilars, formulation innovations, and method-of-use patents.
Compound-specific patents like RU2012136952 face competition from known substances and generic development pathways, making clear claim scope essential for exclusivity.
Patent Family & Related Applications
- It is necessary to investigate if RU2012136952 belongs to a patent family with family members filed in other jurisdictions—particularly Eurasia, the EU, or the US.
- Such family members can influence global market rights and generic challenges.
Patent Challenges
- The Russian patent office’s examination process emphasizes novelty and inventive step.
- The presence of prior art—both domestic and international—can narrow the scope or threaten validity.
- Post-grant opposition mechanisms enable third parties to challenge validity within a specified period.
Implications for Stakeholders
- Pharmaceutical companies should verify claim scope relative to existing patent rights to avoid infringement.
- Patent holders need to monitor competitors' filing activities and possible patent challenges.
- Generic manufacturers may explore designing around claims or assessing patent validity through invalidation procedures.
Conclusion
Patent RU2012136952 appears to provide targeted protection for a pharmaceutical invention in Russia, with claims likely centered on a specific composition or therapeutic method. The scope hinges on precise claim language, with potential limitations if broad claims are vulnerable to prior art. The patent landscape in Russia is competitive but structured to reward genuine innovation, with pathways for patent challenges that stakeholders must consider.
Key Takeaways
- Understanding claim scope is vital: Precise claim language defines the strength and breadth of patent protection, impacting market exclusivity.
- Strategic patent positioning: Patent families and related applications can extend protection across jurisdictions, but must be carefully managed.
- Competitive landscape awareness: Recognizing existing patents, prior art, and potential challenges ensures better risk mitigation.
- Monitoring legal status: Regular updates on the patent’s legal standing, opposition, or potential invalidation proceedings are essential.
- Alignment with global standards: Multi-jurisdictional patent strategies can maximize commercial advantages, especially in a complex IP environment like Russia.
FAQs
-
What is the significance of the claims in RU2012136952 for infringement analysis?
The claims define the legal boundaries of the patent; any product or method infringing these claims may be subject to legal action. Precise claim language determines whether a competitor’s product falls within the scope of protection.
-
How does the Russian patent landscape affect pharmaceutical innovation?
Russia’s patent laws incentivize genuine innovation through a robust examination process. However, the landscape is also receptive to challenges, making patent validity and scope critical for market exclusivity.
-
Can RU2012136952 be challenged or invalidated?
Yes. Under Russian law, third parties can file oppositions or invalidation claims based on prior art or lack of novelty, especially during post-grant periods.
-
What strategies can patent holders employ to defend or extend protection?
They can file supplementary patents (e.g., for formulations or new uses), pursue patent extensions where applicable, and actively monitor potential infringers or invalidation risks.
-
How does the patent landscape influence drug development in Russia?
It encourages innovation by providing exclusive rights but also necessitates thorough patent landscape analysis to avoid infringement and identify opportunities for licensing or strategic partnerships.
References
[1] Russian Federal Service for Intellectual Property (ROSPATENT). Patent database.
[2] Russian Civil Code, Part IV, regarding patent law.
[3] Eurasian Patent Office publications and guidelines.
[4] Domain-specific patent landscape reports (e.g., pharmaceutical patents in Russia).
